PTC Therapeutics
PTCT
#2687
Rank
C$8.56 B
Marketcap
C$106.73
Share price
-0.76%
Change (1 day)
57.27%
Change (1 year)

PTC Therapeutics (PTCT) - Cash on Hand

Cash on Hand as of September 2025 : C$2.33 Billion

According to PTC Therapeutics 's latest financial reports the company has C$2.33 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

PTC Therapeutics - Cash on Hand chart (from 2012 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$1.63 B40.64%
2023-12-31C$1.16 B108.66%
2022-12-31C$0.55 B-43.46%
2021-12-31C$0.98 B-29.96%
2020-12-31C$1.40 B56.94%
2019-12-31C$0.89 B189.24%
2018-12-31C$0.31 B28.94%
2017-12-31C$0.24 B-22.77%
2016-12-31C$0.31 B-33.78%
2015-12-31C$0.47 B28.52%
2014-12-31C$0.36 B141.22%
2013-12-31C$0.15 B5495.26%
2012-12-31C$2.71 M-90.63%
2011-12-31C$28.92 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Vertex Pharmaceuticals
VRTX
C$8.68 B 272.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$1.17 B-49.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
C$0.29 B-87.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
C$2.59 B 11.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C$0.65 B-72.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$13.47 B 477.85%๐Ÿ‡จ๐Ÿ‡ญ Switzerland